Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:RETA

Reata Pharmaceuticals (RETA) Stock Price, News & Analysis

Reata Pharmaceuticals logo

About Reata Pharmaceuticals Stock (NASDAQ:RETA)

Advanced Chart

Key Stats

Today's Range
$172.36
$172.36
50-Day Range
$168.70
$172.36
52-Week Range
$21.83
$172.46
Volume
N/A
Average Volume
1.09 million shs
Market Capitalization
$6.58 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive RETA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Reata Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

RETA Stock News Headlines

Banks aren’t ready for this altcoin—are you?
The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket change.
See More Headlines

RETA Stock Analysis - Frequently Asked Questions

Reata Pharmaceuticals, Inc. (NASDAQ:RETA) released its quarterly earnings results on Monday, November, 8th. The company reported ($1.97) EPS for the quarter, topping the consensus estimate of ($2.32) by $0.35. The company's quarterly revenue was up 428.6% on a year-over-year basis.

Reata Pharmaceuticals (RETA) raised $60 million in an initial public offering on Thursday, May 26th 2016. The company issued 4,000,000 shares at $14.00-$16.00 per share. Citigroup, Cowen and Company and Piper Jaffray served as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Reata Pharmaceuticals investors own include NVIDIA (NVDA), Meta Platforms (META), CrowdStrike (CRWD), Advanced Micro Devices (AMD), Netflix (NFLX), Approach Resources (AREX) and Intel (INTC).

Company Calendar

Last Earnings
11/08/2021
Today
7/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:RETA
CIK
1358762
Fax
N/A
Employees
321
Year Founded
2002

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$311.90 million
Net Margins
N/A
Pretax Margin
-373.40%
Return on Equity
-922.50%
Return on Assets
-73.39%

Debt

Debt-to-Equity Ratio
0.84
Current Ratio
3.21
Quick Ratio
3.19

Sales & Book Value

Annual Sales
$23.48 million
Price / Sales
280.05
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($1.79) per share
Price / Book
-96.29

Miscellaneous

Outstanding Shares
38,150,000
Free Float
27,926,000
Market Cap
$6.58 billion
Optionable
Optionable
Beta
1.42

Social Links

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:RETA) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners